Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

Quotient Diagnostics (Acquired) (AIM: EKF) is Profiled in this Database

Updated At 28 Nov, 2012

Start Free 7 Day Trial Now
Partial description of this company
A1c diabetes testing at the point of care, with results in under 4 minutes

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Quotient Diagnostics (Acquired) (AIM: EKF) plus 4970 other startups.

Start Free 7 Day Trial Now

Learn More About Quotient Diagnostics (Acquired) (AIM: EKF)

Technology/product details


Our Clients